Thank you, Mr. Chair.
Ms. Vanni, thank you for being with us today and for educating us on the importance of these three ongoing pandemics. Although they took a back seat to the COVID‑19 pandemic, they are no less deadly.
I listened carefully to your opening statement, and I was surprised that you gave the whole thing in only one of Canada's official languages. Feel free to answer in the language of Molière, if you so wish.
Mr. Ehsassi referred to the negative effects of COVID‑19 on the fight against AIDS, tuberculosis and malaria. I just mentioned it as well. Nevertheless, there is a positive side to the COVID‑19 pandemic, especially the development of mRNA vaccine technology.
In early 2022, Moderna announced that it would be conducting clinical trials of an mRNA vaccine for AIDS. We also learned that BioNTech planned to conduct a clinical trial of an mRNA vaccine against malaria this year.
Are you able to give us an update on how those clinical trials are going? Are any results available yet?